These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454 [TBL] [Abstract][Full Text] [Related]
5. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance. Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047 [TBL] [Abstract][Full Text] [Related]
6. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Kinsey M; Smith R; Lessnick SL Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343 [TBL] [Abstract][Full Text] [Related]
8. Current Status of Proteomics in Ewing's Sarcoma. Kondo T Proteomics Clin Appl; 2019 May; 13(3):e1700130. PubMed ID: 29992772 [TBL] [Abstract][Full Text] [Related]
11. Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma. Gangwal K; Close D; Enriquez CA; Hill CP; Lessnick SL Genes Cancer; 2010 Feb; 1(2):177-187. PubMed ID: 20827386 [TBL] [Abstract][Full Text] [Related]
12. Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Gangwal K; Sankar S; Hollenhorst PC; Kinsey M; Haroldsen SC; Shah AA; Boucher KM; Watkins WS; Jorde LB; Graves BJ; Lessnick SL Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10149-54. PubMed ID: 18626011 [TBL] [Abstract][Full Text] [Related]
13. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Smith R; Owen LA; Trem DJ; Wong JS; Whangbo JS; Golub TR; Lessnick SL Cancer Cell; 2006 May; 9(5):405-16. PubMed ID: 16697960 [TBL] [Abstract][Full Text] [Related]
14. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma. Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188 [TBL] [Abstract][Full Text] [Related]
15. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells. Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604 [TBL] [Abstract][Full Text] [Related]
16. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma. Ban J; Jug G; Mestdagh P; Schwentner R; Kauer M; Aryee DN; Schaefer KL; Nakatani F; Scotlandi K; Reiter M; Strunk D; Speleman F; Vandesompele J; Kovar H Oncogene; 2011 May; 30(18):2173-80. PubMed ID: 21217773 [TBL] [Abstract][Full Text] [Related]
17. Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma. Owen LA; Lessnick SL Cell Cycle; 2006 Sep; 5(18):2049-53. PubMed ID: 16969112 [TBL] [Abstract][Full Text] [Related]
18. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963 [TBL] [Abstract][Full Text] [Related]
19. EWS/ETS fusions activate telomerase in Ewing's tumors. Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994 [TBL] [Abstract][Full Text] [Related]
20. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis. Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]